期刊文献+

单核细胞人白细胞DR抗原表达的意义及与脓毒症的关系 被引量:3

原文传递
导出
摘要 在脓毒症发展过程中,不仅存在促炎/抗炎反应导致的非特异性免疫功能亢进,还存在着特异性免疫功能抑制,此结果可导致感染易感性增加,加速脓毒症患者死亡,因此,正确评价患者的免疫状态对脓毒症的治疗有重要意义。
出处 《中国危重病急救医学》 CAS CSCD 北大核心 2009年第8期507-509,共3页 Chinese Critical Care Medicine
  • 相关文献

参考文献15

  • 1Volk HD, Reinke P, Krausch D, et al. Monocyte deactivation: rationale for a new therapeutic strategy in sepsis. Intensive Care Med, 1996, 22 (Suppl 4) :S474-481.
  • 2王今达.90年代多脏衰综合征:SIRS与MODS[J].中国危重病急救医学,1995,7(6):324-328. 被引量:69
  • 3Hershman M J, Cheadle WG, Wellhausen SR, et al. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg,1990,77(2):204-207.
  • 4Levy MM,Fink MP, Marshall JC,et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med, 2003, 31 (4): 1250-1256.
  • 5Rangel-Frausto MS, Pittet D, Costigan M,et al. The natural history of the systemic inflammatory response syndrome (SIRS) : a prospective study. JAMA, 1999,273(2) : ]17-123.
  • 6Bone RC. Sir lsaae Newton, sepsis, SIRS,and CARS. Crit Care Med,1996, 24(17):1225-1128.
  • 7Volk HD, Thieme M, Heym S, et al. Alterations in function and phenotype of monocytes from patients with septic disease-predictive value and new therapeutic strategies. Behring Inst Mitt, 1991(88) :208-215.
  • 8Hynninen M, Pettila V, Takkunen O, et al. Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis. Shock, 2003,20 (1) : 1-4.
  • 9Lekkou A, Karakantza M,Mouzaki A, et al. Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol, 2004, 11 (1):161-167.
  • 10Heidecke CD,Hensler T, Weighardt H, et al. Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am J Surg, 1999, 178(4) :288-292.

二级参考文献17

  • 1贺石林.多器官衰竭的发病机制[J].中国危重病急救医学,1995,7(6):333-334. 被引量:15
  • 2王今达,王宝恩.多脏器功能失常综合征(MODS)病情分期诊断及严重程度评分标准(经庐山’95全国危重病急救医学学术会讨论通过)[J].中国危重病急救医学,1995,7(6):346-347. 被引量:1415
  • 3王今达.90年代多脏衰综合征:SIRS与MODS[J].中国危重病急救医学,1995,7(6):324-328. 被引量:69
  • 4金伯泉,细胞和分子免疫学,1995年,213页
  • 5Angus D C,Linde-Zwirble,W T,Lidicker J,et al.Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care[J].Crit Care Med,2001,29:1303-1310.
  • 6Volk H D,Reinke P,Krausch D,et al.Monocyte deactivation:rationale for a new therapeutic strategy in sepsis[J].Intensive Care Med,1996,22(Suppl 4):S474-481.
  • 7Bone R C,Balk R A,Cerra F B,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J].Chest,1992,101:1644-1655.
  • 8LeGall J R,Loirat P,Alperovitch A.APACHE Ⅱ:a severity of disease classification system[J].Crit Care Med,1986,14:754-755.
  • 9Bone R C.Sir Isaac Newton,sepsis,SIRS,and CARS[J].Crit Care Med,1996,24:1125-1128.
  • 10Bone R C.Immunologic dissonance:a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome(MODS)[J].Ann Intern Med,1996,125:680-687.

共引文献203

同被引文献56

引证文献3

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部